Benign Teratoma
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Phase II Trial of the Cyclin-Dependent Kinase Inhibitor PD 0332991 in Patients With Cancer (NCT01037790) | Abramson Cancer Center at Penn Medicine | 2009-10-01 |
Track Benign Teratoma automatically
Every clearance here is in the API, with alerts when new ones post.